
EnquBio
San Diego, CA, United States enqubio.com From their website, Nov 2026
- GLP
Work here? Claim this listing
About
EnquBio is a San Diego-based drug R&D technology and service company that supports pharmaceutical and biotechnology research. It provides preclinical discovery, pharmacology, biomarker, and bioanalysis services from its San Diego facility.
Services
Discovery Biology
Supports target validation and early discovery with genome editing, custom cell line engineering, iPSC models, and mechanism-of-action/exploratory biology studies.
Genome Editing
Provides genome editing services as part of discovery biology workflows.
Cell Line Generation
Generates custom cell lines for discovery and functional studies.
Induced Pluripotent Stem Cell (iPSC) Platform
Uses iPSC model systems for discovery biology and functional assays.
Mechanism of Action (MOA) & Exploratory Biology
Performs exploratory biology studies to link molecular targets to phenotypic outcomes.
Plate-Based Pharmacology
Runs validated and custom assay platforms for high-throughput screening, hit-to-lead progression, and lead optimization.
Compound Management
Supports compound handling for screening and pharmacology workflows.
High-throughput Screening (HTS)
Screens compounds in 384- and 1536-well plates for early discovery programs.
12 more services
- Hit-to-Lead & Lead Optimization
- Assay Development
- High Content Screening (HCS) Capability
- Ex Vivo Pharmacology
- Ex Vivo Tumor Pharmacology
- Blood, PBMC & Primary Immune Cell Pharmacology
- Tissue-Based Ex Vivo & Primary Cell Models
- In Vivo–Ex Vivo Functional Pharmacology
- Integrated In Vivo–Ex Vivo Biomarker & PK/PD Analysis
- In Vivo Pharmacology
- Inflammation & Autoimmune Diseases Models
- Syngeneic and Cell Line-Derived Xenograft (CDX) Models
Capabilities
- Assays and studies
- In vivo
- Bioanalysis
- PK/PD
- HTS
- High-content imaging
- Toxicology
15 more
- High-throughput screening
- High-content screening
- Assay development
- Mechanism of action studies
- Exploratory biology
- Ex vivo pharmacology
- In vivo pharmacology
- PK/PD analysis
- Non-GLP toxicology
- Immunoassay
- Protein quantification
- Western blot
- Protein expression and signaling
- Immunophenotyping
- Cellular biomarkers
- Scale and capacity
- 384-well plates
- 1536-well plates
- Hundreds of thousands of compounds
- Therapeutic areas
- Oncology
- Immuno-oncology
- Inflammation
- Autoimmunity
- Metabolic diseases
Instruments and platforms
- Operetta CLS
- BMG PHERAstar FSX
- PerkinElmer EnVision
- FLIPR Tetra
- ECHO 650
- Bravo
6 more
- Hamilton STAR
- CyBio Well vario
- Apricot iPP
- Cytek Aurora CS
- Cytek Northern Lights
- MSD S-PLEX
Modalities and species
- Modalities
- Cell therapy
- Species and models
- Human tissues
- Animal tissues
- PBMC
- Primary immune cells
- Syngeneic models
- Cell line-derived xenograft (CDX) models
- Humanized immuno-oncology models
- Orthotopic models
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
Details
- Type
- CRO
- Ownership
- Small business, as registered with SAM.gov or stated on their site
- Address
- 11120 Roselle Street San Diego, CA 92121